Frontal white matter integrity in adults with Down syndrome with and without dementia

Neurobiology of Aging

Volumn 35, Issue 7, 2014, Pages 1562-1569

  Powell, David ^a   Caban Holt, Allison ^b   Jicha, Gregory ^b   Robertson, William ^b   Davis, Roberta ^b   Gold, Brian T ^a,b   Schmitt, Frederick A ^b   Head, Elizabeth ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Aging; BPT; Brief praxis test; Dementia questionnaire for persons with mental retardation; Diffusion tensor imaging; DMR; Fractional anisotropy; Severe impairment battery; SIB; Trisomy 21

Indexed keywords

ADULT; AGING; ARTICLE; BRIEF PRAXIS TEST; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CORPUS CALLOSUM; DEMENTIA; DIFFUSION TENSOR IMAGING; DISEASE ASSOCIATION; DOWN SYNDROME; FEMALE; FRACTIONAL ANISOTROPY; FRONTAL LOBE; HUMAN; MALE; PARIETAL LOBE; PRIORITY JOURNAL; PSYCHOLOGIC TEST; SEVERE IMPAIRMENT BATTERY; WHITE MATTER;

AGING; BPT; BRIEF PRAXIS TEST; DEMENTIA QUESTIONNAIRE FOR PERSONS WITH MENTAL RETARDATION; DIFFUSION TENSOR IMAGING; DMR; FRACTIONAL ANISOTROPY; SEVERE IMPAIRMENT BATTERY; SIB; TRISOMY 21;

ADULT; ANISOTROPY; DEMENTIA; DIFFUSION TENSOR IMAGING; DOWN SYNDROME; FEMALE; FRONTAL LOBE; HUMANS; MALE; MIDDLE AGED; NEUROIMAGING; NEUROPSYCHOLOGICAL TESTS;

EID: 84903366115     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.01.137     Document Type: Article

References (48)

1. Aylward E.H., Burt D.B., Thorpe L.U., Lai F., Dalton A. Diagnosis of dementia in individuals with intellectual disability. J.Intellect. Disabil. Res. 1997, 41(Pt 2):152-164.
2. Back S.A., Kroenke C.D., Sherman L.S., Lawrence G., Gong X., Taber E.N., Sonnen J.A., Larson E.B., Montine T.J. White matter lesions defined by diffusion tensor imaging in older adults. Ann. Neurol. 2011, 70:465-476.
3. Ball S.L., Holland A.J., Treppner P., Watson P.C., Huppert F.A. Executive dysfunction and its association with personality and behaviour changes in the development of Alzheimer's disease in adults with Down syndrome and mild to moderate learning disabilities. Br. J. Clin. Psychol. 2008, 47(Pt 1):1-29.
4. Basser P.J., Pajevic S., Pierpaoli C., Duda J., Aldroubi A. Invivo fiber tractography using DT-MRI data. Magn. Reson. Med. 2000, 44:625-632.
5. Beacher F., Daly E., Simmons A., Prasher V., Morris R., Robinson C., Lovestone S., Murphy K., Murphy D.G. Alzheimer's disease and Down's syndrome: an invivo MRI study. Psychol. Med. 2009, 39:675-684.
6. Bucur B., Madden D.J., Spaniol J., Provenzale J.M., Cabeza R., White L.E., Huettel S.A. Age-related slowing of memory retrieval: contributions of perceptual speed and cerebral white matter integrity. Neurobiol. Aging 2008, 29:1070-1079.
7. Chao L.L., Decarli C., Kriger S., Truran D., Zhang Y., Laxamana J., Villeneuve S., Jagust W.J., Sanossian N., Mack W.J., Chui H.C., Weiner M.W. Associations between white matter hyperintensities and beta amyloid on integrity of projection, association, and limbic fiber tracts measured with diffusion tensor MRI. PLoS One 2013, 8:e65175.
8. Cooper S.A., Prasher V.P. Maladaptive behaviours and symptoms of dementia in adults with Down's syndrome compared with adults with intellectual disability of other aetiologies. J.Intellect. Disabil. Res. 1998, 42(Pt 4):293-300.
9. Dalton A., Fedor B. DYSPRAXIA Scale for Adults with Down Syndrome 1997, NYS Institute for Basic Research in Developmental Disabilities, Staten Island, New York.
10. Evenhuis H.M. Further evaluation of the dementia questionnaire for persons with mental retardation (DMR). J.Intellect. Disabil. Res. 1996, 40:369-373.
11. Gold B.T., Powell D.K., Andersen A.H., Smith C.D. Alterations in multiple measures of white matter integrity in normal women at high risk for Alzheimer's disease. Neuroimage 2010, 52:1487-1494.
12. Gold B.T., Powell D.K., Xuan L., Jicha G.A., Smith C.D. Age-related slowing of task switching is associated with decreased integrity of frontoparietal white matter. Neurobiol. Aging 2010, 31:512-522.
13. Grabner G. Symmetric atlasing and model based segmentation: an application to the hippocampus in older adults. Med. Image Comput. Comput. Assist. Interv. 2006, 4191:9.
14. Head E., Lott I.T., Patterson D., Doran E., Haier R.J. Possible compensatory events in adult Down syndrome brain prior to the development of Alzheimer disease neuropathology: targets for nonpharmacological intervention. J.Alzheimers Dis. 2007, 11:61-76.
15. Holland A.J., Hon J., Huppert F.A., Stevens F. Incidence and course of dementia in people with Down's syndrome: findings from a population-based study. J.Intellect. Disabil. Res. 2000, 44(Pt 2):138-146.
16. Koski L., Iacoboni M., Mazziotta J.C. Deconstructing apraxia: understanding disorders of intentional movement after stroke. Curr. Opin. Neurol. 2002, 15:71-77.
17. Krasuski J.S., Alexander G.E., Horwitz B., Rapoport S.I., Schapiro M.B. Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease. Am. J. Psychiatry 2002, 159:74-81.
18. Landt J., D'Abrera J.C., Holland A.J., Aigbirhio F.I., Fryer T.D., Canales R., Hong Y.T., Menon D.K., Baron J.C., Zaman S.H. Using positron emission tomography and carbon 11-labeled Pittsburgh compound B to image brain fibrillar beta-amyloid in adults with down syndrome: safety, acceptability, and feasibility. Arch. Neurol. 2011, 68:890-896.
19. Lott I.T. Neurological phenotypes for Down syndrome across the life span. Prog. Brain Res. 2012, 197:101-121.
20. Lott I.T., Doran E., Nguyen V.Q., Tournay A., Head E., Gillen D.L. Down syndrome and dementia: a randomized, controlled trial of antioxidant supplementation. Am. J. Med. Genet. A 2011, 155A:1939-1948.
21. Lott I.T., Doran E., Nguyen V.Q., Tournay A., Movsesyan N., Gillen D.L. Down syndrome and dementia: seizures and cognitive decline. J.Alzheimers Dis. 2012, 29:177-185.
22. Madden D.J., Bennett I.J., Burzynska A., Potter G.G., Chen N.K., Song A.W. Diffusion tensor imaging of cerebral white matter integrity in cognitive aging. Biochim. Biophys. Acta 2012, 1822:386-400.
23. Madden D.J., Bennett I.J., Song A.W. Cerebral white matter integrity and cognitive aging: contributions from diffusion tensor imaging. Neuropsychol. Rev. 2009, 19:415-435.
24. Matsuoka Y., Andrews H.F., Becker A.G., Gray A.J., Mehta P.D., Sano M.C., Dalton A.J., Aisen P.S. The relationship of plasma abeta levels to dementia in aging individuals with Down syndrome. Alzheimer Dis. Assoc. Disord. 2009, 23:315-318.
25. Mattiace L.A., Kress Y., Davies P., Ksiezak-Reding H., Yen S.H., Dickson D.W. Ubiquitin-immunoreactive dystrophic neurites in Down's syndrome brains. J.Neuropathol. Exp. Neurol. 1991, 50:547-559.
26. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease. Neurology 1984, 34:939-944.
27. Nelson L., Lott I., Touchette P., Satz P., D'Elia L. Detection of Alzheimer disease in individuals with Down syndrome. Am. J. Ment. Retard. 1995, 99:616-622.
28. Nelson L.D., Siddarth P., Kepe V., Scheibel K.E., Huang S.C., Barrio J.R., Small G.W. Positron emission tomography of brain beta-amyloid and tau levels in adults with Down syndrome. Arch. Neurol. 2011, 68:768-774.
29. Nichols T.E., Holmes A.P. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum. Brain Mapp. 2002, 15:1-25.
30. Panisset M., Roudier M., Saxton J., Boller F. Severe impairment battery. A neuropsychological test for severely demented patients. Arch. Neurol. 1994, 51:41-45.
31. Petreska B., Adriani M., Blanke O., Billard A.G. Apraxia: a review. Prog. Brain Res. 2007, 164:61-83.
32. Pfefferbaum A., Sullivan E.V. Increased brain white matter diffusivity in normal adult aging: relationship to anisotropy and partial voluming. Magn. Reson. Med. 2003, 49:953-961.
33. Pinter J.D., Eliez S., Schmitt J.E., Capone G.T., Reiss A.L. Neuroanatomy of Down's syndrome: a high-resolution MRI study. Am. J. Psychiatry 2001, 158:1659-1665.
34. Roher A.E., Weiss N., Kokjohn T.A., Kuo Y.M., Kalback W., Anthony J., Watson D., Luehrs D.C., Sue L., Walker D., Emmerling M., Goux W., Beach T. Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease. Biochemistry 2002, 41:11080-11090.
35. Roth G.M., Sun B., Greensite F.S., Lott I.T., Dietrich R.B. Premature aging in persons with Down syndrome: MR findings. Am. J. Neuroradiol 1996, 17:1283-1289.
36. Saito Y., Oka A., Mizuguchi M., Motonaga K., Mori Y., Becker L.E., Arima K., Miyauchi J., Takashima S. The developmental and aging changes of Down's syndrome cell adhesion molecule expression in normal and Down's syndrome brains. Acta Neuropathol. (Berl) 2000, 100:654-664.
37. Schupf N., Sergievsky G.H. Genetic and host factors for dementia in Down's syndrome. Br. J. Psychiatry 2002, 180:405-410.
38. Sexton C.E., Kalu U.G., Filippini N., Mackay C.E., Ebmeier K.P. Ameta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease. Neurobiol. Aging 2011, 32:2322.e5-2322.e18.
39. Shahani N., Brandt R. Functions and malfunctions of the tau proteins. Cell Mol. Life Sci. 2002, 59:1668-1680.
40. Smith S.M., Jenkinson M., Johansen-Berg H., Rueckert D., Nichols T.E., Mackay C.E., Watkins K.E., Ciccarelli O., Cader M.Z., Matthews P.M., Behrens T.E. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006, 31:1487-1505.
41. Stricker N.H., Schweinsburg B.C., Delano-Wood L., Wierenga C.E., Bangen K.J., Haaland K.Y., Frank L.R., Salmon D.P., Bondi M.W. Decreased white matter integrity in late-myelinating fiber pathways in Alzheimer's disease supports retrogenesis. Neuroimage 2009, 45:10-16.
42. Teipel S.J., Alexander G.E., Schapiro M.B., Moller H.J., Rapoport S.I., Hampel H. Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry. Brain 2004, 127:811-824.
43. Wang D.S., Bennett D.A., Mufson E.J., Mattila P., Cochran E., Dickson D.W. Contribution of changes in ubiquitin and myelin basic protein to age-related cognitive decline. Neurosci. Res. 2004, 48:93-100.
44. White N.S., Alkire M.T., Haier R.J. Avoxel-based morphometric study of nondemented adults with Down syndrome. Neuroimage 2003, 20:393-403.
45. Wimberger D.M., Roberts T.P., Barkovich A.J., Prayer L.M., Moseley M.E., Kucharczyk J. Identification of "premyelination" by diffusion-weighted MRI. J.Comput. Assist Tomogr. 1995, 19:28-33.
46. Wisniewski K., Wisniewski H., Wen G. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann. Neurol. 1985, 17:278-282.
47. Xu J., Chen S., Ahmed S.H., Chen H., Ku G., Goldberg M.P., Hsu C.Y. Amyloid-beta peptides are cytotoxic to oligodendrocytes. J.Neurosci. 2001, 21:RC118.
48. Zhang J.H., Sampogna S., Morales F.R., Chase M.H. Age-related ultrastructural changes in hypocretinergic terminals in the brainstem and spinal cord of cats. Neurosci. Lett. 2005, 373:171-174.